Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Patients With Stage IIB-IVA Cervical Cancer: A Randomized Phase III Trial

Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Patients With Stage IIB-IVA Cervical Cancer: A Randomized Phase III Trial

BackgroundIn this trial, we aimed to assess the efficacy and safety of radiotherapy with nedaplatin or cisplatin in patients with locally advanced cervical cancer.MethodsWe conducted an open-label, non-inferiority, phase III, randomized, controlled trial. Eligible patients with stage IIB-IVA cervica...

Full description

Bibliographic Details
Main Authors: Shasha He, Yan Wang, Yulin Lai, Xinping Cao, Yufeng Ren, Yong Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Oncology
Subjects:
cervical carcinoma
nedaplatin
cisplatin
toxicity
survival
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.798617/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.798617/full

Similar Items